Previous 10 | Next 10 |
AnPac Bio-Medical Science (ANPC) +95% on Q3 record test volume.Mmtec (MTC) +50%.Yunji (YJ) +46% on deal with Bytedance's live streaming platform.Weidai (WEI) +30%.Safe-T Group Ltd (SFET) +22% on Q3 results.Molecular Data (MKD) +22%.21Vianet Group (VNET) +20%...
Are Analysts Right About Some Of These Penny Stocks? After several weeks of rallies in the stock market, investors are continuing to pay attention to penny stocks . On November 24th, the stock market had one of the best days in months. Tuesday saw the Dow Jones Industrial Average sh...
Cocrystal Pharma (COCP): Q3 GAAP EPS of -$0.05.Revenue of $0.49M (flat Y/Y) misses by $0.09M.Shares +0.3% PM.10QPress Release For further details see: Cocrystal Pharma misses on revenue
– Continued progress of COVID-19 development programs with additional preclinical studies of coronavirus protease inhibitors (3CL) underway and lead preclinical molecule selection expected by year end – – Ongoing Merck collaboration to discover and develop i...
BOTHELL, WA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announ...
– Live video webcast with the Cocrystal management team, on Thursday, November 12 th at 12:00 PM EST – BOTHELL, WA, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”),...
– New in vitro data demonstrating antiviral activity with lead compound CC-42344 against Xofluza (baloxavir)-resistant H1N1 strain – – Company continues to advance IND-enabling studies for Phase 1 clinical study in 2021 – BOTHELL, WA, Oc...
Penny Stocks Under $1 To Watch Right Now; 1 Up Over 65% After-Hours Penny stocks come in all shapes and sizes. They range anywhere from the cheapest penny stocks at $0.0001 to the high end of $4.9999. Whether you’re buying the cheapest of these or the “most expensi...
BOTHELL, WA, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP) The following is being released by Cocrystal Pharma, Inc. pursuant to an order of the United States District Court, District of New Jersey, regarding Agreement of Settlement. UNITED STA...
– Live video webcast with Chairman and CEO, Dr. Gary Wilcox, on Monday, September 14 th at 3:30 PM EDT – BOTHELL, WA, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), ...
News, Short Squeeze, Breakout and More Instantly...
Cocrystal Pharma Inc. Company Name:
COCP Stock Symbol:
NASDAQ Market:
Cocrystal Pharma Inc. Website:
BOTHELL, Wash., July 18, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) today reported favorable safety and tolerability results from the single-ascending dose (SAD) cohorts of the Phase 1 study in healthy volunteers wit...
BOTHELL, Wash., June 20, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc .’s (Nasdaq: COCP) novel, broad-spectrum antiviral CC-42344 inhibits activity in the highly pathogenic avian influenza A (H5N1) PB2 protein recently identified in infected dairy cattle, according to recently ...
Topline single ascending dose (SAD) Phase 1 results of oral CDI-988, the first potential pan-coronavirus-pan-norovirus oral antiviral, expected in the second quarter of 2024 Enrollment completed in Phase 2a influenza A human challenge study of oral CC-42344, with topline results expected ...